CJ CheilJedang and ADM Form Joint Venture to Bolster U.S. Amino Acid…

Event summary

CJ CheilJedang and ADM will form a joint venture to strengthen U.S. production of feed-grade amino acids, leveraging CJ’s fermentation technology and ADM’s manufacturing footprint.
The joint venture will combine CJ’s Fort Dodge, Iowa, and Piracicaba, Brazil, fermentation facilities with ADM’s Decatur, Illinois, amino acid plant.
CJ will be the majority owner of the joint venture, which will have exclusive rights to manufacture and sell feed-grade amino acids in the Americas.
The launch date is subject to regulatory approvals and customary closing activities.

The big picture

The joint venture aims to address the risk of U.S. domestic production of feed-grade amino acids, particularly lysine, by combining CJ’s fermentation technology with ADM’s manufacturing capabilities. This move comes amid recent regulatory actions to eliminate unfair trade practices affecting U.S. imports of lysine from China, highlighting the strategic importance of securing domestic production. The collaboration underscores the growing emphasis on supply chain resilience and food security in the agricultural sector.

What we're watching

Regulatory Approval: The pace at which regulatory approvals are secured will determine the joint venture’s timeline for operational launch.
Cost Competitiveness: Whether the joint venture can achieve enhanced cost competitiveness through combined assets and capabilities.
Market Dynamics: How the joint venture will impact global supply chain resilience and U.S. food security amid challenging market conditions.